Concord Medical Services Holdings Cash Flow Conversion Efficiency
Concord Medical Services Holdings cash flow conversion efficiency. Based on the latest financial reports, Concord Medical Services Holdings (CCM) has a cash flow conversion efficiency ratio of 0.008x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($16.03 Million) by net assets ($2.09 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Concord Medical Services Holdings (2007–2025)
Cash flow conversion efficiency of Concord Medical Services Holdings from 2007 to 2025. This chart illustrates how Concord Medical Services Holdings's cash flow conversion efficiency has evolved over time, based on yearly financial data. View CCM live share price for real-time trading data and today's change.
Concord Medical Services Holdings Cash Flow Conversion Ratio Explained
Concord Medical Services Holdings cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Concord Medical Services Holdings Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Concord Medical Services Holdings ranked by their cash flow conversion efficiency. Also see market value of Concord Medical Services Holdings for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Pertama Digital Berhad
KLSE:8532
|
-0.001x |
|
EDGE TOTAL INTELLIGENCE
F:Q5I
|
0.330x |
|
Dfcity Group Bhd
KLSE:5165
|
0.025x |
|
Menteng Heritage Realty Tbk PT
JK:HRME
|
-0.001x |
|
Panda Financial Holding Corp Ltd
SHG:600599
|
0.403x |
|
Neo-Concept International Group Holdings Limited Ordinary Shares
NASDAQ:NCI
|
0.008x |
|
TME PHARM.CONF.IPO EO 1-
F:0N6A
|
N/A |
|
Txcom SA
PA:ALTXC
|
-0.023x |
Annual Cash Flow Conversion Efficiency for Concord Medical Services Holdings (2007–2025)
The table below shows the annual cash flow conversion efficiency of Concord Medical Services Holdings from 2007 to 2025. Review free cash flow generation of Concord Medical Services Holdings to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.85 Billion | $-201.82 Million | -0.109x | +55.63% |
| 2024-12-31 | $1.62 Billion | $-397.75 Million | -0.246x | -55.36% |
| 2023-12-31 | $1.75 Billion | $-276.47 Million | -0.158x | -47.21% |
| 2022-12-31 | $2.02 Billion | $-216.69 Million | -0.108x | +17.91% |
| 2021-12-31 | $2.74 Billion | $-359.31 Million | -0.131x | -36.84% |
| 2020-12-31 | $2.40 Billion | $-229.77 Million | -0.096x | +7.44% |
| 2019-12-31 | $1.89 Billion | $-195.35 Million | -0.103x | -509.26% |
| 2018-12-31 | $2.27 Billion | $-38.59 Million | -0.017x | -164.43% |
| 2017-12-31 | $1.01 Billion | $26.73 Million | 0.026x | +141.55% |
| 2016-12-31 | $1.23 Billion | $-78.08 Million | -0.063x | +48.11% |
| 2015-12-31 | $1.43 Billion | $-175.14 Million | -0.122x | -144.84% |
| 2014-12-31 | $1.80 Billion | $490.38 Million | 0.272x | +156.21% |
| 2013-12-31 | $2.44 Billion | $259.03 Million | 0.106x | -4.05% |
| 2012-12-31 | $2.34 Billion | $259.51 Million | 0.111x | +64.74% |
| 2011-12-31 | $2.04 Billion | $137.10 Million | 0.067x | -18.92% |
| 2010-12-31 | $2.30 Billion | $190.97 Million | 0.083x | +31.50% |
| 2009-12-31 | $2.15 Billion | $135.88 Million | 0.063x | -23.79% |
| 2008-12-31 | $565.02 Million | $46.77 Million | 0.083x | -35.52% |
| 2007-12-31 | $54.13 Million | $6.95 Million | 0.128x | -- |
About Concord Medical Services Holdings
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other tre… Read more